Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study.
Upadhyaya
H P
HP
Brady
K T
KT
Sethuraman
G
G
Sonne
S C
SC
Malcolm
R
R
D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D019970:Cocaine-Related Disorders / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D015897:Comorbidity; D003511:Cyclohexanols / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010865:Pilot Projects; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride